{
  "resourceType": "PlanDefinition",
  "id": "ANCDT38",
  "url": "http://fhir.org/guides/who/anc-cds/PlanDefinition/ANCDT38",
  "identifier": [ {
    "use": "official",
    "value": "ANC.DT.38"
  } ],
  "name": "Deworming and malaria prophylaxis",
  "title": "ANC.DT.38 Deworming and malaria prophylaxis",
  "type": {
    "coding": [ {
      "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
      "code": "eca-rule"
    } ]
  },
  "status": "active",
  "experimental": false,
  "date": "2021-01-24T10:38:52-07:00",
  "description": "IF the woman is currently in a malaria-endemic setting, or in an area where there is greater than 20% prevalence of infection with any soil-transmitted helminths, THEN she should receive preventative treatment accordingly",
  "action": [ {
    "title": "ANC.DT.38 Deworming and malaria prophylaxis",
    "trigger": [ {
      "type": "named-event",
      "name": "ANC.B10. Counselling, in-facility management and treatment"
    } ],
    "action": [ {
      "title": "Provide malaria prophylaxis",
      "description": "\"Conduct counselling on malaria prevention\"",
      "textEquivalent": "Sleeping under an insecticide-treated bednet and the importance of seeking care and getting treatment as soon as she has any symptoms",
      "documentation": [ {
        "type": "citation",
        "label": "WHO ANC recommendations (2016): C.6. Malaria prevention: intermittent preventive treatment in pregnancy (IPTp) (3)"
      } ],
      "condition": [ {
        "kind": "applicability",
        "expression": {
          "description": "Malaria-endemic setting = TRUE",
          "language": "text/x-pseudo"
        }
      } ]
    }, {
      "title": "Do not give IPTp-SP, because woman is taking co-trimoxazole",
      "description": "\"IPTp-SP dose 1 provided\" = FALSE\n\"IPTp-SP dose 2 provided\" = FALSE\n\"IPTp-SP dose 3 provided\" = FALSE",
      "textEquivalent": "IF the woman is currently taking co-trimoxazole, even in a malaria-endemic setting, she should not receive any dose of IPTp-SP. Women who are taking co-trimoxazole SHOULD NOT receive IPTp-SP. Taking both co-trimoxazole and IPTp-SP together can enhance side-effects, especially haematological side-effects such as anaemia.",
      "documentation": [ {
        "type": "citation",
        "label": "WHO ANC recommendations (2016): C.6. Malaria prevention: intermittent preventive treatment in pregnancy (IPTp) (3)"
      } ],
      "condition": [ {
        "kind": "applicability",
        "expression": {
          "description": "(Malaria-endemic setting = TRUE)\n  AND (Current medications\" = \"Co-trimoxazole\")",
          "language": "text/x-pseudo"
        }
      } ]
    }, {
      "title": "Conduct deworming",
      "description": "\"Preventive antihelminthic treatment provided\"",
      "textEquivalent": "In areas with a population prevalence of infection with any soil-transmitted helminths of 20% or higher OR a population anaemia prevalence 40% or higher, preventive anthelminthic treatment is recommended for pregnant women after the first trimester as part of worm infection reduction programmes",
      "documentation": [ {
        "type": "citation",
        "label": "WHO ANC recommendations (2016): C.4. Preventive anthelminthic treatment (3)"
      } ],
      "condition": [ {
        "kind": "applicability",
        "expression": {
          "description": "\"Population prevalence of soil-transmitted helminth infection\" ≥ 20% ",
          "language": "text/x-pseudo"
        }
      } ]
    }, {
      "title": "Conduct deworming",
      "description": "\"Preventive antihelminthic treatment provided\"",
      "textEquivalent": "In areas with a population prevalence of infection with any soil-transmitted helminths of 20% or higher OR a population anaemia prevalence 40% or higher, preventive anthelminthic treatment is recommended for pregnant women after the first trimester as part of worm infection reduction programmes",
      "documentation": [ {
        "type": "citation",
        "label": "WHO ANC recommendations (2016): C.4. Preventive anthelminthic treatment (3)"
      } ],
      "condition": [ {
        "kind": "applicability",
        "expression": {
          "description": "\"Population prevalence of anaemia\" ≥ 40%",
          "language": "text/x-pseudo"
        }
      } ]
    } ]
  } ]
}